Today: 24 June 2026
Nasdaq edges lower in after-hours as AI chip fall spurs margin chatter
24 June 2026
2 mins read

US stock futures edge higher as Micron (NASDAQ:MU) draws AI spotlight

NEW YORK, June 24, 2026, 06:05 EDT

Nasdaq futures traded a bit higher but Dow futures dipped before the open.

Nasdaq 100 futures were up 0.41% early Wednesday at 05:40 a.m. EDT, bouncing after two days of tech losses. S&P 500 futures edged 0.09% higher. Dow futures fell 0.16%. All numbers are premarket, not the open. Source: Markets Insider.

NYSE scheduled a normal session, running from 9:30 a.m. to 4 p.m. ET. June 24 is not shown as a holiday on the exchange’s 2026 calendar.

Tech came off session lows Tuesday, but sellers still had control. The Philadelphia SE Semiconductor index dropped 7.9%. S&P 500 technology fell 3.7%. Nasdaq Composite was down 2.21%. Investors pulled money after fresh doubt over debt-driven AI spending. “Questions about all the spending” followed recent AI headlines, said Thomas Martin, senior portfolio manager at Globalt. Reuters

Micron Technology led premarket gains. Micron’s stock climbed 3.8% ahead of the bell, while Sandisk was up 3.5%. Both dropped about 13% last session. Micron is set to report earnings after markets close. Even with the recent drop, Micron is up 268% this year. “I think people are going to get the blowout quarter that they expect, but I don’t expect the stock to continue to rise,” said Jay Woods, chief market strategist at Freedom Capital Markets. Reuters

Micron matters on this move because it’s a direct read on AI. The Street isn’t just focused on demand now. There are fresh doubts about whether demand will stay strong enough to back the prices memory stocks have hit after the recent run.

Cerebras has lowered its margin forecast again. The AI chip company is guiding for full-year adjusted gross margins of 38% to 41%. That’s a step down from the 47% it posted in Q1. Nvidia is still in the mid-70% range. CFO Bob Komin said that relying on outside capacity “will depress core cloud and other services margin temporarily.” Reuters

FedEx shares fell 7% before the bell as the company’s Federal Express unit posted a 7.7% operating margin, down from 8.4% a year ago. FedEx has spun off its Freight business and faces calls to lift returns in its delivery operations. UPS remains the main comparison point for investors.

Fed stays front and center with new data coming. The Bureau of Economic Analysis will release the next personal consumption expenditures price index on June 25. The Fed tracks inflation with the PCE, which measures what people spend on goods and services. The latest April reading showed prices rising 3.8% from a year earlier.

Dollar stayed firm with investors sticking to safe-haven trades while U.S.-Iran talks are in focus. U.S. stock futures tacked on 0.1% to 0.4%, showing little movement in a quiet session worldwide. Oil lost over 1%. The dollar reached a one-year high against major currencies. “A sign of instability,” said Michael McCarthy at Moomoo Securities Australia of the recent swings. Reuters

Wednesday’s early gains may not last. Weak numbers from Micron, rising rate-hike odds, or fresh concern over the U.S.-Iran deal could push sellers back into crowded AI names. If PCE comes in strong on Thursday, it gets harder for investors to ignore.

Barclays and Stifel each boosted their S&P 500 year-end targets to 7,800 on Tuesday, citing solid earnings. Stifel’s Thomas Carroll noted “stock concentration sits at 40-year highs,” warning the rally needs participation beyond megacap tech if it’s going to spread out. Bullish positioning is still in place, but space is tighter. Reuters

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Micron, Qualcomm, Intel Lead AI Stocks Recovery Amid Market Rebound
    June 24, 2026, 9:12 AM EDT. Micron Technology, Qualcomm, and Intel spearheaded a recovery rally in AI-focused stocks following a sharp decline in the previous session. The bounce back highlights renewed investor confidence in semiconductor and technology sectors linked to artificial intelligence. This reversal comes as broader market sentiment improves, with foundational tech shares regaining ground after recent losses. Industry observers note the recovery underscores the volatility but ongoing interest in AI-driven innovation stocks. The rebound may signal a stabilization phase ahead in technology equities, with key players like Micron and Qualcomm regaining upward momentum.
Arqit Quantum (NASDAQ:ARQQ) climbs after fresh U.S. quantum security deals, SEC filing

Arqit Quantum (NASDAQ:ARQQ) climbs after fresh U.S. quantum security deals, SEC filing

24 June 2026
Arqit Quantum surged 35.6% after U.S. executive orders on June 22 spotlighted post-quantum cryptography, the encryption Arqit sells, with shares quoted up again premarket; a Millennium-linked group briefly held over 5% but fell below that threshold, and a $7 million legal settlement was approved, resolving all U.S. class actions against the company.
Tencent stock up as firm tests WeCom AI tool, files share buyback

Tencent stock up as firm tests WeCom AI tool, files share buyback

24 June 2026
Tencent soared 3.38% to HK$428.80 after its WeCom app began limited rollout of Dayuan, an AI agent built on DeepSeek V4, with the news helping push shares up over 5% in afternoon trade; Tencent also repurchased 1.183 million shares for HK$500.7 million, while the AI push raises spending and adoption risks remain.
Ambu falls after Danske Bank downgrades on urology concerns

Ambu falls after Danske Bank downgrades on urology concerns

24 June 2026
Ambu shares plunged 9.4% to 56.75 DKK after Danske Bank downgraded the stock to “sell” and slashed its price target to 58 DKK, citing faster-than-expected competition and price pressure in urology, weak ureteroscope traction, and a limited product portfolio versus rivals, despite ongoing share buybacks and recent endoscopy growth.
Quantinuum stock trades higher with QNT price moving well above reported revenue
Previous Story

Quantinuum stock trades higher with QNT price moving well above reported revenue

Pfizer (NYSE:PFE) churns as investors price in bigger cancer pipeline discount after Seagen drug miss
Next Story

Pfizer (NYSE:PFE) churns as investors price in bigger cancer pipeline discount after Seagen drug miss

Go toTop